Brand Name: Eglaro

Generic Name: Ertugliflozin

Dosage Strength: 15mg

Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

Packing: 14 Tablets

Description and Usage:

Eglaro is a medication brand that typically contains the active ingredient Ertugliflozin in 15mg tablet form. Ertugliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Here’s a description of Ertugliflozin and its potential effects:

Ertugliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. These drugs work by inhibiting the reabsorption of glucose in the kidneys, thereby increasing the excretion of glucose in the urine and lowering blood sugar levels.

Ertugliflozin works by blocking the SGLT2 protein in the kidneys, which is responsible for the reabsorption of glucose back into the bloodstream. By inhibiting this protein, ertugliflozin promotes the excretion of excess glucose in the urine, leading to a reduction in blood sugar levels.

Brand Name: Dapwiz

Generic Name: Dapagliflozin

Dosage Strength: 5mg

Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

Packing: 10 Tablets

Description and Usage:

Dapwiz is a medication brand that typically contains the active ingredient Dapagliflozin in 5mg tablet form. Dapagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Here’s a description of Dapagliflozin and its potential effects:

Dapagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. These drugs work by inhibiting the reabsorption of glucose in the kidneys, thereby increasing the excretion of glucose in the urine and lowering blood sugar levels.

Dapagliflozin works by blocking the SGLT2 protein in the kidneys, which is responsible for the reabsorption of glucose back into the bloodstream. By inhibiting this protein, dapagliflozin promotes the excretion of excess glucose in the urine, leading to a reduction in blood sugar levels.

Brand Name: Viglip-M

Generic Name: Vildagliptin + Metformin

Dosage Strength: 50mg Vildagliptin + 500mg Metformin

Manufacturer: Atco Pharmaceutical (Pvt) Ltd.

Packing: 14 Tablets

Description and Usage:

Viglip-M (Vildagliptin + Metformin) 50mg/500mg tablets are prescribed for the treatment of type 2 diabetes mellitus in adults. It combines the effects of two different classes of antidiabetic medications:

1. Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which help to lower blood sugar levels by stimulating insulin release and reducing glucagon secretion.
2. Metformin: Metformin is a biguanide antidiabetic medication. It works by decreasing glucose production in the liver, improving insulin sensitivity in peripheral tissues, and reducing intestinal glucose absorption.

• Vildagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones (such as glucagon-like peptide-1 or GLP-1 and glucose-dependent insulinotropic polypeptide or GIP). These hormones stimulate insulin release and suppress glucagon secretion, thereby lowering blood sugar levels.
• Metformin: Decreases hepatic glucose production, enhances peripheral glucose uptake and utilization, and reduces intestinal glucose absorption. These actions collectively help to lower blood glucose levels in patients with type 2 diabetes.